Sangamo Therapeutics, Inc. (SGMO)

Sangamo Therapeutics Revenue

In the year 2024, Sangamo Therapeutics had annual revenue of $57.80M, down -67.20%. Sangamo Therapeutics had revenue of $7.55M in the quarter ending December 31, 2024, with 269.78% growth.

• Revenue (ttm): $57.80M
• Revenue Growth: -67.20%
• P/S Ratio: 2.44
• Revenue / Employee: $315,847
• Employees: 183
• Market Cap: 167.81M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	57.80M	-118.43M	-67.20%
Dec 31, 2023	176.23M	64.93M	58.34%
Dec 31, 2022	111.30M	598.00K	0.54%
Dec 31, 2021	110.70M	-7.49M	-6.34%
Dec 31, 2020	118.19M	15.76M	15.39%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.